ATE411320T1 - Mikrokristall und medizinische zusammensetzung, die diesen enthält - Google Patents
Mikrokristall und medizinische zusammensetzung, die diesen enthältInfo
- Publication number
- ATE411320T1 ATE411320T1 AT04807132T AT04807132T ATE411320T1 AT E411320 T1 ATE411320 T1 AT E411320T1 AT 04807132 T AT04807132 T AT 04807132T AT 04807132 T AT04807132 T AT 04807132T AT E411320 T1 ATE411320 T1 AT E411320T1
- Authority
- AT
- Austria
- Prior art keywords
- microcrystal
- same
- composition containing
- medical composition
- microcrystals
- Prior art date
Links
- 239000013081 microcrystal Substances 0.000 title abstract 3
- 239000002245 particle Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003413725 | 2003-12-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE411320T1 true ATE411320T1 (de) | 2008-10-15 |
Family
ID=34675069
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04807132T ATE411320T1 (de) | 2003-12-11 | 2004-12-09 | Mikrokristall und medizinische zusammensetzung, die diesen enthält |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20070049634A1 (de) |
| EP (1) | EP1693374B1 (de) |
| JP (1) | JPWO2005056561A1 (de) |
| KR (1) | KR20060121163A (de) |
| CN (1) | CN1845927A (de) |
| AT (1) | ATE411320T1 (de) |
| AU (1) | AU2004297132A1 (de) |
| CA (1) | CA2550136A1 (de) |
| DE (1) | DE602004017220D1 (de) |
| ES (1) | ES2314484T3 (de) |
| NO (1) | NO20063134L (de) |
| TW (1) | TW200522943A (de) |
| WO (1) | WO2005056561A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111885988A (zh) | 2018-04-11 | 2020-11-03 | 宝洁公司 | 一次性吸收制品 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100447674B1 (ko) * | 1997-04-15 | 2004-09-08 | 교와 핫꼬 고교 가부시끼가이샤 | 삼환식 화합물 |
| US6383520B1 (en) * | 1998-06-26 | 2002-05-07 | Chugai Seiyaku Kabushiki Kaisha | Fine powder of L-α-aminoadipic acid derivative, oral solid preparations containing the same, and method for treatment of bulk powders |
| JP2002053580A (ja) * | 2000-08-09 | 2002-02-19 | Kyowa Hakko Kogyo Co Ltd | 三環系化合物の製造法 |
| PL366219A1 (en) * | 2000-08-14 | 2005-01-24 | Teva Pharmaceutical Industries Ltd. | Micronized torsemide |
| WO2002045691A2 (en) * | 2000-12-06 | 2002-06-13 | Pharmacia Corporation | Laboratory scale milling process |
| WO2002078711A1 (en) * | 2001-03-30 | 2002-10-10 | Kyowa Hakko Kogyo Co., Ltd. | Remedies for vesical hyperesthesia |
| US7354949B2 (en) * | 2001-03-30 | 2008-04-08 | Kyowa Hakko Kogyo Co., Ltd. | Therapeutic agent for bladder irritative symptoms associated with benign prostatic hyperplasia |
| CA2442463A1 (en) * | 2001-03-30 | 2002-10-10 | Kyowa Hakko Kogyo Co., Ltd. | Therapeutic agent for overactive bladder |
| WO2003041704A1 (fr) * | 2001-11-13 | 2003-05-22 | Kyowa Hakko Kogyo Co., Ltd. | Agent preventif ou remede destine au prurit |
-
2004
- 2004-12-03 TW TW093137286A patent/TW200522943A/zh unknown
- 2004-12-09 WO PCT/JP2004/018773 patent/WO2005056561A1/ja not_active Ceased
- 2004-12-09 CN CNA2004800256578A patent/CN1845927A/zh active Pending
- 2004-12-09 US US10/582,328 patent/US20070049634A1/en not_active Abandoned
- 2004-12-09 JP JP2005516247A patent/JPWO2005056561A1/ja not_active Withdrawn
- 2004-12-09 AT AT04807132T patent/ATE411320T1/de not_active IP Right Cessation
- 2004-12-09 KR KR1020067011372A patent/KR20060121163A/ko not_active Withdrawn
- 2004-12-09 DE DE602004017220T patent/DE602004017220D1/de not_active Expired - Fee Related
- 2004-12-09 ES ES04807132T patent/ES2314484T3/es not_active Expired - Lifetime
- 2004-12-09 EP EP04807132A patent/EP1693374B1/de not_active Expired - Lifetime
- 2004-12-09 CA CA002550136A patent/CA2550136A1/en not_active Abandoned
- 2004-12-09 AU AU2004297132A patent/AU2004297132A1/en not_active Abandoned
-
2006
- 2006-07-06 NO NO20063134A patent/NO20063134L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2314484T3 (es) | 2009-03-16 |
| US20070049634A1 (en) | 2007-03-01 |
| NO20063134L (no) | 2006-09-08 |
| EP1693374A1 (de) | 2006-08-23 |
| AU2004297132A1 (en) | 2005-06-23 |
| JPWO2005056561A1 (ja) | 2007-07-05 |
| CA2550136A1 (en) | 2005-06-23 |
| CN1845927A (zh) | 2006-10-11 |
| WO2005056561A1 (ja) | 2005-06-23 |
| TW200522943A (en) | 2005-07-16 |
| DE602004017220D1 (de) | 2008-11-27 |
| EP1693374A4 (de) | 2007-01-03 |
| KR20060121163A (ko) | 2006-11-28 |
| EP1693374B1 (de) | 2008-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003211560A1 (en) | Novel phenylalanine derivative | |
| IL176005A0 (en) | 2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same | |
| AU2003247668A1 (en) | Non-irritating antiperspirant compositions containing acidic antiperspirant active | |
| IL165119A0 (en) | C-aryl glucoside derivatives and pharmaceutical compositions containing the same | |
| AU2002343728A1 (en) | Methods and compositions related to irm compounds and toll-like receptor pathways | |
| AU2003290734A1 (en) | Novel compounds as pharmaceutical agents | |
| AU2003271510A1 (en) | Formulation of oral compositions comprising arsenic trioxide and methods of use thereof | |
| EP1543821A4 (de) | TOPISCHES PRûPARAT | |
| AU2003211453A1 (en) | External compositions for the skin | |
| AU2002315131A1 (en) | Aminediols as agents for the treatment of alzheimer's disease | |
| WO2003020963A3 (en) | Proteins in type 2 diabetes | |
| AU2002368133A1 (en) | 1,3-azole derivative and medicinal composition containing the derivative for treatment for thombosis | |
| BRPI0408423A (pt) | composições farmacêuticas compreendendo uma combinação de rapamicina ou seus derivados e pimecrolimus para o tratamento de doenças mediadas imunologicamente e por inflamação | |
| AU2003273310A1 (en) | Substituted aminoethers for the treatment of alzheimer's disease | |
| WO2004024077A3 (en) | Novel composition and methods for the treatment of psoriasis | |
| AU2001255580A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| ATE411320T1 (de) | Mikrokristall und medizinische zusammensetzung, die diesen enthält | |
| TWI347948B (en) | Novel 2',5'-oligoadenylic acid compositions | |
| AU2003283648A1 (en) | Compounds as radioligands for the diagnosis of disease | |
| AU5576298A (en) | Novel amide derivatives and medicinal compositions thereof | |
| WO2004048381A3 (en) | Pyrazoloazepine compounds as pharmaceutical agents | |
| AU2002342498A1 (en) | Organic compounds | |
| ZA200510138B (en) | Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions | |
| ZA200600241B (en) | Orodispersible pharmaceutical composition of an antithrombotic compound | |
| AU2003294952A1 (en) | 3,3-dimethyl-8-oxoisoquinolines for medical purposes, methods for the production thereof, medicaments containing said compounds and the use of the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |